CUE icon

Cue Biopharma

97 hedge funds and large institutions have $241M invested in Cue Biopharma in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

2.37% less ownership

Funds ownership: 66.16%63.79% (-2.4%)

17% less capital invested

Capital invested by funds: $291M → $241M (-$49.8M)

87% less call options, than puts

Call options by funds: $359K | Put options by funds: $2.72M

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$359K
Puts
$2.72M
Net Calls
Net Calls Change

Top Buyers

1 +$5.98M
2 +$3.79M
3 +$2.46M
4
Millennium Management
Millennium Management
New York
+$2.28M
5
Goldman Sachs
Goldman Sachs
New York
+$2.2M

Top Sellers

1 -$17.7M
2 -$5.06M
3 -$2.37M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.12M
5
BL
Bleichroeder LP
New York
-$938K
Name Holding Trade Value Shares
Change
Change in
Stake
76
$66K
77
$50K
78
$45K
79
$43.9K
80
$42K
81
$41K
82
$31K
83
$25K
84
$23K
85
$19K
86
$15K
87
$13K
88
$10K
89
$7K
90
$5K
91
$3K
92
$3K
93
$2K
94
$2K
95
$1K
96
$1K
97
$215
98
99
100